Allison C. Hoffman Sells 8,426 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 8,426 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total transaction of $230,114.06. Following the transaction, the general counsel now directly owns 146,126 shares in the company, valued at $3,990,701.06. The trade was a 5.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link.

Phreesia Stock Performance

Shares of PHR opened at $27.26 on Friday. The company’s 50 day moving average price is $23.87 and its 200 day moving average price is $22.97. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $29.16. The company has a market capitalization of $1.58 billion, a PE ratio of -18.55 and a beta of 0.94. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The firm had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company’s revenue was up 16.6% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.58) earnings per share. Research analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Institutional Trading of Phreesia

A number of institutional investors and hedge funds have recently modified their holdings of the company. R Squared Ltd acquired a new stake in shares of Phreesia in the fourth quarter worth $30,000. Wesbanco Bank Inc. lifted its stake in shares of Phreesia by 76.9% in the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock worth $1,157,000 after buying an additional 20,000 shares during the last quarter. Franklin Resources Inc. lifted its stake in shares of Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after buying an additional 42,973 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after buying an additional 55,934 shares during the last quarter. Finally, M&T Bank Corp lifted its stake in shares of Phreesia by 4.6% in the third quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock worth $801,000 after buying an additional 1,535 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PHR has been the topic of several recent analyst reports. Citigroup upped their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. KeyCorp increased their price target on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Robert W. Baird cut their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 price target on shares of Phreesia in a research note on Friday, January 10th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.